Fractionation and other clinical considerations in boron neutron capture therapy.
作者信息
Durrant K R, Hopewell J W
机构信息
Department of Radiotherapy and Oncology, Churchill Hospital, Oxford, England.
出版信息
Strahlenther Onkol. 1989 Feb-Mar;165(2-3):231-3.
PMID:2494739
Abstract
摘要
相似文献
1
Fractionation and other clinical considerations in boron neutron capture therapy.
Strahlenther Onkol. 1989 Feb-Mar;165(2-3):231-3.
2
Method of in situ dosimetry in boron neutron capture therapy.
Strahlenther Onkol. 1989 Feb-Mar;165(2-3):109-12.
3
Development of dose measuring system for thermal neutron capture therapy.
Strahlenther Onkol. 1989 Feb-Mar;165(2-3):112-5.
4
Dose bracketing in boron neutron capture therapy.
Strahlenther Onkol. 1989 Feb-Mar;165(2-3):229-30.
5
An overview: radiation sources, beam quality, dosimetry and spectroscopy in neutron capture therapy.
Strahlenther Onkol. 1989 Feb-Mar;165(2-3):67-9.
6
Biological effects of intermediate-energy neutrons and their relevance to boron neutron capture therapy.
Strahlenther Onkol. 1989 Feb-Mar;165(2-3):193-6.
7
A design study of an accelerator-based epithermal neutron source for boron neutron capture therapy.
Strahlenther Onkol. 1989 Feb-Mar;165(2-3):75-8.
8
Optimization of fast neutron spectra available for neutron capture therapy.
Strahlenther Onkol. 1989 Feb-Mar;165(2-3):107-9.
9
Neutron capture therapy with gadolinium-157.
Strahlenther Onkol. 1989 Feb-Mar;165(2-3):156-8.
10
Analytical modeling for neutron capture therapy.
Strahlenther Onkol. 1989 Feb-Mar;165(2-3):186-8.
Zotero 插件